Lung cancer trials in China

In China 1144 Also abroad 2746

182 of 1144 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer
Where
Shanwei
Age
18 years to 80 years
People
2,000
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07880106
No phaseTaking people
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Where
Beijing
Age
18 years and over
People
950
Run by
Beijing Cancer Prevention & Treatment Society
See details and how to joinNCT06422546
No phaseTaking people
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Where
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Huzhou, Jiangmen, Jinan, Kaifeng, Lanzhou, Nanchang, Nanjing, Nantong, Ningbo, Shanghai, Shengyang, Shenzhen, Shijiazhuang, Taiyuan, Taizhou, Tianjin, Ürümqi, Wuhan, Wuxi, Xi'an, Yinchuan, Zhanjiang, Zhengzhou, Zunyi
Age
18 years and over
People
800
Run by
Hoffmann-La Roche
See details and how to joinNCT06862869
No phaseTaking people
Real-World Outcomes of Sevabertinib in HER2-Mutant Advanced NSCLC: A Bidirectional Cohort Study
Where
Qionghai
Age
18 years and over
People
16
Run by
Ruijin Hospital
See details and how to joinNCT07880353
No phaseTaking people
68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis
Where
Nanjing
Age
18 years to 75 years
People
20
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07914764
No phaseTaking people
ePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis
Where
Hubei
Age
18 years and over
People
200
Run by
Qian Chu
See details and how to joinNCT07912190
No phaseTaking people
Exploration of Whole-Brain Radiotherapy Combined With PD-1 Inhibitors on Brain Injury
Where
Guiyang
Age
18 years to 75 years
People
42
Run by
Guizhou Medical University
See details and how to joinNCT07905937
No phaseNot yet taking people in China
Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance
Where
Wuhan
Age
18 years and over
People
3,000
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07882758
No phaseTaking people
Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.
Where
Shanghai
Age
18 years to 90 years
People
294
Run by
Shanghai Chest Hospital
See details and how to joinNCT07681245
No phaseTaking people
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
Where
Beijing
Age
18 years to 80 years
People
470
Run by
Sun Yat-sen University
See details and how to joinNCT06644430
No phaseTaking people
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
Where
Beijing
Age
18 years and over
People
3,000
Run by
AstraZeneca
See details and how to joinNCT07316062
No phaseTaking people
Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study
Where
Guangzhou
Age
18 years and over
People
265
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT07696832
No phaseNot yet taking people in China
Diagnostic Performance of an AI-Based Multi-Omics Model for Early Lung Cancer
Where
Beijing, Changsha
Age
18 years to 75 years
People
1,050
Run by
Beijing Chao Yang Hospital
See details and how to joinNCT07882628
No phaseTaking people
Barriers and Facilitators of Persistence With Adjuvant Osimertinib
Where
Beijing
Age
18 years and over
People
100
Run by
AstraZeneca
See details and how to joinNCT07542210
No phaseTaking people
CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC
Where
Chengdu
Age
18 years and over
People
590
Run by
AstraZeneca
See details and how to joinNCT07413757
No phaseTaking people
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Where
Beijing
Age
18 years to 75 years
People
120
Run by
Peking University First Hospital
See details and how to joinNCT07039474
No phaseTaking people
Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection
Where
Wuhan
Age
18 years and over
People
604
Run by
Tongji Hospital
See details and how to joinNCT07841249
No phaseTaking people
Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC
Where
Wuhan
Age
18 years to 75 years
People
100
Run by
Tongji Hospital
See details and how to joinNCT07837739
No phaseTaking people
Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD
Where
Foshan, Guangzhou, Shantou, Zhongshan
Age
18 years and over
People
180
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT05457049
No phaseTaking people
Multimodal AI Predicts High-risk Pathology in Lung Cancer Associated With Cystic Airspaces
Where
Changsha
Age
18 years and over
People
600
Run by
Central South University
See details and how to joinNCT07820423
No phaseTaking people
Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China
Where
Beijing, Cangzhou, Dongguan, Fuzhou, Guangzhou, Huzhou, Jinan, Nanjing, Nanning, Ningbo, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjing, Wuhan, Wuxi, Yangzhou, Zhengzhou
Age
18 years and over
People
200
Run by
AstraZeneca
See details and how to joinNCT07161388
No phaseNot yet taking people in China
TROP2 NMR Concordance Study
Where
Beijing, Guangzhou, Shanghai
Age
18 years and over
People
3,400
Run by
AstraZeneca
See details and how to joinNCT07624318
No phaseTaking people
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
Where
Beijing, Shanghai
Age
18 years and over
People
2,572
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07806604
No phaseTaking people
Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
Where
Changsha
People
500
Run by
Central South University
See details and how to joinNCT07066813
No phaseTaking people
Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
Where
Chongqing
Age
30 years to 80 years
People
10
Run by
958th Army Hospital of the Chinese People's Liberation Army
See details and how to joinNCT07783971